ASMB
ASSEMBLY BIOSCIENCES, INC.
Next earnings Aug 4, 2026 · consensus $-0.63 EPS, $8.77M rev
Last earnings -1.4% on 2026-05-07
$26.74
▲ +10.22%$26.74▲ +53.77%
over 1Y
L $17.08EODHDH $38.50
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+10.2%
1W+6.3%
1M-2.4%
3M-3.5%
YTD-20.8%
1Y+53.8%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 10 analysts
Strong Buy
Revenue grew 153.5% YoY; but unprofitable (net margin -8.5%).
ASSEMBLY BIOSCIENCES, INC. shows $72.3M in FY2025 revenue (+153.5% YoY), a -8.5% net margin, and -3.0% ROE.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | — | — | — | $28.5M | $72.3M |
| Gross profit | — | — | — | — | — |
| Operating income | -$133M | -$94.1M | -$64.6M | -$45.4M | -$12.1M |
| Net income | -$130M | -$93.1M | -$61.2M | -$40.2M | -$6.12M |
| Diluted EPS | -$3.00 | -$23.08 | -$13.38 | -$6.69 | -$0.55 |
| Net margin | — | — | — | -140.9% | -8.5% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$366M
EV / EBITDA—
EV / Sales5.1
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-1.4%
FCF yield-9.7%
Quality & risk
ROIC (est.)-4.6%
Free cash flow-$41.2M
Total debt$419K
Net cash$58.0M
Altman Z-Score1.57 distress
Piotroski F-Score3/7
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+111.4%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsSome governance/structural items recently, but no outright red flags.
- 8-K Officer / director change2026-06-05
- 8-K Material agreement2026-05-26
- 8-K Reg FD disclosure2026-05-22
- 8-K Earnings results2026-05-07
- 10-Q Quarterly report2026-05-07
- DEF 14A Proxy statement2026-04-22
- 8-K Officer / director change2026-03-30
- 8-K Earnings results2026-03-19
- S-3 Shelf registration (potential raise)2026-03-19
Recent filings
all on EDGAR ↗4Period ending 2026-06-172026-06-18open ↗4Period ending 2026-03-292026-06-05open ↗4Period ending 2026-03-292026-06-05open ↗4Period ending 2026-06-042026-06-05open ↗4Period ending 2026-06-042026-06-05open ↗4Period ending 2026-06-042026-06-05open ↗4Period ending 2026-06-042026-06-05open ↗4Period ending 2026-06-042026-06-05open ↗4Period ending 2026-06-042026-06-05open ↗4Period ending 2026-03-292026-06-05open ↗4Period ending 2026-03-292026-06-05open ↗4Period ending 2026-03-292026-06-05open ↗
Frequently asked
- Is ASSEMBLY BIOSCIENCES, INC. (ASMB) a buy?
- ASMB currently carries a Hold rating with 2/5 conviction, derived from its latest SEC filings. Revenue grew 153.5% YoY; but unprofitable (net margin -8.5%).
- What is ASSEMBLY BIOSCIENCES, INC.'s quality score?
- ASMB scores 57.35294117647058/100 (grade C) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001426800, latest 10-Q filed 2026-05-07) · EODHD · as of 6/22/2026, 11:30:49 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.